Cervical cancer often develops without symptoms in its early stages, meaning many women only become aware of the condition when it has progressed to a more serious stage. However, cervical cancer is one of the cancers whose development process is relatively well understood.
Its progression can be identified from HPV infection and precancerous cell changes to the development of cancer. This makes cervical cancer one of the cancers with significant potential for prevention through vaccination and early detection through routine screening.
Understanding the causes of cervical cancer early can help you take the right preventive steps, from HPV vaccination and maintaining reproductive health to undergoing Pap smear tests as recommended.
Cervical cancer is cancer that develops in the cervix, the lower part of the uterus that connects to the vagina.
The disease generally develops gradually, beginning with a persistent high-risk Human Papillomavirus (HPV) infection. This infection can cause abnormal or precancerous cell changes before potentially progressing to invasive cancer.
Because this process can take several years, screening plays an important role in detecting cellular changes before they develop into cancer.
The primary cause of cervical cancer is persistent infection with high-risk types of Human Papillomavirus (HPV), particularly HPV types 16 and 18. Most HPV infections are naturally cleared by the body's immune system.
However, when a high-risk HPV infection persists for a long time, the virus can trigger changes in cervical cells that may eventually develop into cancer. Several factors can increase the risk of cervical cancer, including:
Exposure to HPV can occur once a person becomes sexually active. Exposure at a young age is one factor to consider when taking steps to prevent HPV infection.
Having multiple sexual partners can increase the likelihood of HPV exposure. People infected with HPV may not show any symptoms, so transmission can occur without either person being aware of the infection.
Harmful substances in cigarettes can affect the body's ability to fight HPV infection. Smoking is also associated with an increased risk of cervical cell changes.
Conditions such as HIV or the use of medications that suppress the immune system can make it more difficult for the body to control HPV infection. As a result, the infection may be more likely to persist.
Long-term use of oral hormonal contraceptives has been associated with an increased risk of cervical cancer under certain circumstances. However, this does not mean that women should stop taking birth control pills. Discuss contraceptive options with your doctor based on your needs and health condition.
A history of certain sexually transmitted infections may be associated with an increased risk of cervical cancer. However, it is important to understand that persistent high-risk HPV infection remains the primary cause of cervical cancer.
Cervical cancer is one of the cancers with significant potential for prevention. Prevention involves two main approaches: HPV vaccination as primary prevention and screening for early detection.
The HPV vaccine is an important preventive measure against certain types of HPV that can cause cervical cancer. With advances in medical technology, several types of HPV vaccines are available, each offering protection against different HPV types:
These developments allow for protection against a broader range of HPV types, including high-risk types associated with cervical cancer.
HPV vaccination is recommended before a person is exposed to HPV, according to the recommended age and vaccination schedule. However, it is important to remember that the HPV vaccine does not protect against every HPV type that can cause cervical cancer.
Receiving the HPV vaccine does not mean that a person no longer needs Pap smear tests. The HPV vaccine protects against specific HPV types but does not cover every virus type that may cause cervical cancer.
Therefore, screening remains necessary even for those who have completed their HPV vaccination. A Pap smear is a screening test used to detect changes in cervical cells that may develop into precancerous conditions. In addition to Pap smears, HPV DNA testing can also be used to detect high-risk HPV infections.
The recommended starting age and screening intervals should be determined based on applicable guidelines, the screening method used, medical history, and a doctor's advice.
The World Health Organization (WHO) encourages women to undergo screening using a high-performance test at least by the ages of 35 and 45. Screening may begin earlier or follow a different schedule depending on national guidelines and individual circumstances.
In addition to vaccination and screening, the following steps may help reduce the risk of cervical cancer:
The success of national HPV vaccination programs demonstrates that cervical cancer prevention can have a significant impact at the population level.
Australia is one example. Through its national HPV vaccination program, which began in 2007, the country has successfully reduced HPV prevalence by approximately 90% among eligible vaccinated groups.
In 2021, Australia also recorded no cases of cervical cancer among women under the age of 25. The country is now projected to become the first to eliminate cervical cancer as a public health problem by 2035.
This success is not solely the result of vaccination. It is also supported by national screening programs, early detection, and the treatment of precancerous lesions. This demonstrates that cervical cancer is not simply a disease to be treated after it develops; it can also be prevented through well-planned and sustained efforts.
Cervical cancer is primarily caused by persistent high-risk HPV infection, rather than hereditary factors alone. A family history may be associated with certain risk factors, but it is not the primary cause of cervical cancer. Therefore, HPV vaccination and screening remain important preventive measures for every woman, in accordance with medical recommendations.
Yes. The HPV vaccine can help prevent infection with certain HPV types that are the leading cause of cervical cancer. Vaccination provides important protection, particularly when administered before a person is exposed to HPV.
However, the vaccine does not protect against every high-risk HPV type. Therefore, women who have received the HPV vaccine should still undergo cervical cancer screening according to their age and their doctor's recommendations.
Screening frequency depends on age, the screening method used, medical history, and previous test results. Pap smears and HPV DNA tests are screening methods that can help detect cellular changes or high-risk HPV infections before they develop into cancer.
The WHO recommends screening with a high-performance test at least twice during a woman's lifetime, at ages 35 and 45. More specific screening schedules should follow national guidelines and be adjusted to each individual's circumstances. Do not wait for symptoms to appear before getting screened, as precancerous cell changes often cause no symptoms.
Consult your doctor promptly if you experience any of the following symptoms:
These symptoms do not necessarily indicate cervical cancer, but they should be evaluated by a doctor to determine their cause.
Cervical cancer has a recognizable progression, which means there are opportunities to prevent it through HPV vaccination and early detection with routine screening. Do not delay taking preventive measures.